The BioSkin Crossfire™ is a supportive and lightweight hinged knee brace, ideal for people recovering from a variety of knee injuries who want to remain mobile and active while they recover. The Crossfire™ offers increased joint stability while allowing for a full range of motion.
The pull-on inner sleeve facilitates donning by holding the brace in place, so the user has both hands free to adjust the fit. The sleeve provides compression to the entire knee to help reduce swelling, provide pain relief and enhance proprioception.
The Crossfire is available with a Standard or Conforma hinge. The Standard Hinge is a simple Bicentric aluminium hinge that uses aircraft grade aluminium to deliver the stability your patients need in a lightweight brace. The Conforma Hinge is made of injection moulded Nylon. The hinge Conforms to the patient’s natural anatomy, whilst providing the required stability during joint rehabilitation.
The Wraparound brace is made form BioSkins proprietary 2SL fabric. The face of this soft, breathable, compressive fabric is Velcro-compatible, making the brace adjustable to fit nearly any leg. Lightweight Cirrus material is used behind the knee. This back panel is sewn in a slightly flexed position, virtually eliminating bunching behind the knee.
Wraparound: The entire front panel is hook and loop compatible, making it easy to achieve a perfect fit on virtually any leg. A great option for patients with limited flexibility or hand strength.
Indications for use of Crossfire™
» Common injuries
» ACL & PCL injury
» MCL & LCL injury
» Meniscus tears
» Knee instability
» Knee sprains
Features and benefits of Crossfire™
» No bunching behind the knee
» Lightweight Standard Aluminium or Conforma Hinge
» Soft inner sleeve
» Stabilising straps
» Features lightweight and compressive material over the patella
» Universal design fits the left or right knee
» Latex-free material
Crossfire Conforma Sell Sheet
Crossfire Conforma Clinical paper – Valgus Knee Bracing Studies (Crossfire OA technology)
There are no reviews yet.